EPI-003

N/A

Report date: 2025/12/19 17:00:15

Base Information

Drug NameEPI-003
Drug Alias NameEPI-003
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Gene therapy > LNP
Mechanisms of Actioncovalently closed circular DNA inhibitorsHepatitis B virus inhibitors
Targetscovalently closed circular DNAHepatitis B virus
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEpigenic Therapeutics Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesEpigenic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A